Biotech Stock News (SYN) (ZFGN) (ARNA) (OREX) (VVUS)

Synthetic Biologics (NYSE:SYN) On Thursday December 3, 2015 Synthetic Biologics announced positive phase 2 results for the prevention of a bacterial infection known as C. difficile. The drug the company is using to combat against this bacterial infection is known as SYN-004. This drug was created for the purpose of clearing out IV fluid, such … Read more

Orexigen (OREX) Therapeutics Stock | Can It Recover?

Orexigen Therapeutics, Inc. (NASDAQ: OREX) Orexigen took a major hit in the market earlier this week. Unfortunately, the company announced that it will be stopping testing on the cardiovascular candidate known as Contrave. As a result, the stock dived. However, today we’re starting to see gains for the first time since the bad news; leading … Read more

Biotech Stock News (OREX) (ABBV) (PCYC) (GILD) (OHRP)

Orexigen Therapeutics (OREX) Shares of Orexigen Therapeutics were up 40% on 3/3/15 when the company announced that early safety data showed that Contrave was not only safe to take but in addition it was able to reduce a patient’s risk of generating cardiovascular health issues such as a heart-attack. Contrave was approved by the FDA … Read more